Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Cross-Kingdom Assemblage Clearance via Anionic Chondroitin Sulfate Nanohybrid Aggregates

Award Number: R03DE035552
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/09/2026
PERIOD OF PERFORMANCE END DATE: 07/08/2028

Group Awards By:

View Award Description

Cross-Kingdom Assemblage Clearance via Anionic Chondroitin Sulfate Nanohybrid Aggregates - PROJECT SUMMARY/ABSTRACT Early childhood caries (ECC) preferentially affects nearly 25% of American children of the pre-school age. The impact of ECC to both the child and family is devasting both emotionally and financially - as the cost of restorative treatment is both substantial and time consuming. ECC preferentially affects those of low socioeconomic status and specifically, those with poor oral hygiene leading, a high sugar diet and chronic tooth-borne biofilms comprising Streptococcus mutans and Candida albicans. Current ECC prevention protocols include fluoride treatment combined with various antimicrobial regimens, however, evidence supporting the currently available antimicrobial agents in long term success is lacking potentially attributed to microbial resistance and/or poor efficacy against S. mutans-C. albicans assemblages. We have developed anionic, nanohybrid aggregate formulations comprised of chondroitin sulfate A (CSA) and cerium oxide nanoparticles (CeO2-NP) that achieve plaque reduction via selective clearance of S. mutans (and assembled C. albicans) reducing their contribution to adherent plaque formation with minimal toxicity. In contrast, single metal oxide nanoparticles (MxOy-NP) often researched for anti-biofilm activity are often plagued with poor selectivity and enhanced toxicity. The central hypothesis is based on the fluid nanohybrid aggregate structure where both CSA and CeO2-NP are surface exposed, such that i) CSA aids in the targeting of cationic protein(s) on the S. mutans surface over random salivary proteins and the ii) nanoceria aggregate structure facilitates extended aggregation reducing penetration of soft tissues. This proposal tests the above hypotheses with the development of two independent Aims and the benefit of an interdisciplinary team of investigators. In Aim 1, we utilize literature based pull down assays and antibody labeling experiments to identify the key protein (or proteins) on the S. mutans surface mediating the phenotypic effects resulting from CeO2-NP-CSA(-B) treatment. In Aim-2, 3D oral soft tissue models will be repeatedly dosed with CeO2-NP-CSA(-B) along with CeO2-NP to establish their effects on barrier integrity, inflammation and toxicity over time. Completion of the above aims will define a new area of selective, non-toxic and inexpensive topical therapeutics that can achieve targeted removal of pathogens associated with the incidence and severity of ECC. Long term goals involve testing the nanohybrid aggregates in advanced in vivo studies relevant to patient care of this at-risk population.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $320,660 )
2026	2026	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Oral Diseases and Disorders Research	000	1	7/14/2026	NEW	$320,660
														Subtotal = $320,660

Grand Total All Awards = $320,660

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cross-Kingdom Assemblage Clearance via Anionic Chondroitin Sulfate Nanohybrid Aggregates

Award Number: R03DE035552

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/09/2026

PERIOD OF PERFORMANCE END DATE: 07/08/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer